Viome Life Sciences's $67M Extension Round Is A Good Sign For Diagnostics
crunchbase.com
tech
2022-10-18 19:33:02

Email Facebook Twitter LinkedIn When the Biden Administration began sending out at-home COVID-19 testing kits, the vision was to keep a stock of easy-to-use diagnostic tools in the medicine cabinet alongside bandages and bottles of pain relief drugs. 
That led to a slew of startups entering the little-known diagnostics world. 
Now we see Viome Life Sciences, an at-home diagnostics startup, announcing on Tuesday it raised a $67 million extension round towards its Series C. This brings total financing for the company to more than $150 million, according to the company.
